High Purity MOTSc Peptide Suppliers in China Leading Biopharmaceutical Factory
Looking for high-purity MOTS-c in 10MG, 20MG, and 40MG specifications? We are leading China suppliers and a professional factory providing pharmaceutical-grade MOTS-c for metabolic research and insulin sensitivity studies.
About this product
Product information from the supplier.
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a highly specialized 16-amino-acid peptide encoded directly within the mitochondrial DNA. Recognized as a potent cellular signaling molecule, MOTS-c serves as a critical link between mitochondrial function and nuclear gene expression, effectively coordinating the body's response to metabolic demands.
Often characterized as an "exercise mimetic," MOTS-c plays a pivotal role in enhancing metabolic flexibility and managing energy homeostasis. By helping the body adapt to metabolic stress, this peptide supports the regulation of glucose metabolism and insulin sensitivity, making it a subject of significant interest in the field of genetic engineering and bio-pharmaceutical research.
Detailed Parameters
| Chemical Name | MOTS-c Peptide | Sequence Length | 16 Amino Acids |
|---|---|---|---|
| Source | Mitochondrial DNA (12S rRNA) | Molecular Type | Signaling Peptide |
| Primary Function | Metabolic Regulation | Mechanism | Exercise Mimetic |
| Application | Bio-pharmaceutical Research | Target Area | Mitochondrial Homeostasis |
| Purity Grade | Pharmaceutical Grade | Storage Condition | Ultra-low Temperature |
Key Advantages
Metabolic Flexibility
Optimizes the body's ability to switch between fuel sources, improving overall energy efficiency.
Stress Adaptation
Enhances cellular resilience against metabolic stress and environmental pressures.
Exercise Mimetic
Simulates the metabolic benefits of physical activity at a cellular signaling level.
Energy Management
Regulates cellular energy expenditure and improves mitochondrial efficiency.
Precision Encoding
Directly encoded by mitochondrial DNA for high biological specificity and activity.
Signal Coordination
Facilitates seamless communication between the mitochondria and the cell nucleus.
Product Gallery
Management Platforms
Batch Traceability
Full tracking of every peptide batch from raw material to final synthesis.
Quality Control
Rigorous HPLC and Mass Spectrometry testing to ensure 99%+ purity.
Cold Chain Logistics
Strict temperature-controlled shipping to maintain peptide stability.
Regulatory Compliance
Adherence to global bio-pharmaceutical manufacturing standards and GMP.
Custom Synthesis
Flexible scaling options for research, pilot, and commercial production.
Technical Support
Expert consultation on peptide handling and mitochondrial assay integration.
Investment Return Comparison
| Metric | Standard Peptides | MOTS-c Bio-Engineered |
|---|---|---|
| Metabolic Impact | General/Low | Highly Targeted |
| Signaling Efficiency | Standard | Enhanced (Mito-Nuclear) |
| Research Value | Moderate | High (Innovative) |
| Stability Rate | Standard | Optimized High |
| Market Demand | Saturated | Rapidly Growing |
Frequently Asked Questions
Unlike standard peptides, MOTS-c is encoded by mitochondrial DNA and acts as a mitochondrial-derived peptide (MDP), allowing it to regulate nuclear gene expression and mimic the effects of exercise.
MOTS-c triggers biological pathways that are normally activated during physical exercise, such as improved glucose uptake and enhanced metabolic flexibility, without the need for physical exertion.
In the pharmaceutical industry, MOTS-c is used as a lead compound for developing treatments for metabolic disorders, obesity, and mitochondrial dysfunction through advanced synthesis techniques.
Due to its peptide nature, MOTS-c should be stored in a lyophilized state at -20°C or -80°C to prevent degradation and ensure long-term bioactivity.
Yes, through advanced solid-phase peptide synthesis (SPPS) and genetic engineering, MOTS-c can be produced at scale while maintaining high purity and structural integrity.
It is primarily used in studying mitochondrial-to-nuclear signaling, metabolic syndrome research, and the development of novel therapies for insulin resistance.